Please Wait
Applying Filters...
menu
    • menu
    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    Centrient is a leading manufacturer of Beta-Lactam Antibiotics and a provider of next-generation Statins and Antifungals.

    Virtual Booth

    Contact Supplier

    Moehs Group, a reference company in the production of pharmaceutical active ingredients.

    Virtual Booth

    Contact Supplier

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Onvansertib

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 35,423Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Cardiff Oncology Presents Onvansertib Data for CMML at ASH 2025
    Cardiff Oncology Presents Onvansertib Data for CMML at ASH 2025

    08 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/08/3201965/0/en/Cardiff-Oncology-Announces-Clinical-Data-from-Investigator-Sponsored-Trial-with-Onvansertib-in-Chronic-Myelomonocytic-Leukemia-at-ASH-2025.html

    GLOBENEWSWIRE
    08 Dec 2025
    Share Share
    Cardiff Oncology Reports Q3 2025 Results & Business Update
    Cardiff Oncology Reports Q3 2025 Results & Business Update

    06 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/06/3183076/0/en/Cardiff-Oncology-Reports-Third-Quarter-2025-Results-and-Provides-Business-Update.html

    GLOBENEWSWIRE
    06 Nov 2025
    Share Share
    Cardiff Updates Colorectal Cancer Data, Stock Plummets
    Cardiff Updates Colorectal Cancer Data, Stock Plummets

    30 Jul 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/investors-whale-cardiff-sinking-stock-after-seeing-updated-colorectal-cancer-data

    FIERCE BIOTECH
    30 Jul 2025
    Share Share
    Cardiff Oncology Completes Enrollment in Phase 2 CRDF-004 Trial
    Cardiff Oncology Completes Enrollment in Phase 2 CRDF-004 Trial

    15 Apr 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/04/15/3062116/0/en/Cardiff-Oncology-Announces-Completion-of-Enrollment-in-Phase-2-CRDF-004-Trial-Evaluating-Onvansertib-for-the-Treatment-of-First-line-RAS-mutated-Metastatic-Colorectal-Cancer.html

    GLOBENEWSWIRE
    15 Apr 2025
    Share Share
    Cardiff teases onvansertib efficacy in colorectal cancer
    Cardiff teases onvansertib efficacy in colorectal cancer

    01 Mar 2024

    // Ayisha Sharma ENDPTS

    https://endpts.com/cardiff-teases-plk1-inhibitor-efficacy-in-colorectal-cancer-ahead-of-first-line-readout/

    Ayisha Sharma ENDPTS
    01 Mar 2024
    Share Share
    Cardiff Oncology Announces Plans for a Randomized Trial in mCRC
    Cardiff Oncology Announces Plans for a Randomized Trial in mCRC

    12 Sep 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/cardiff-oncology-announces-plans-for-a-randomized-trial-in-metastatic-colorectal-cancer-mcrc-durability-of-responses-in-ongoing-phase-1b2-trial-in-mcrc-and-additional-business-updates-301622266.html

    PRNEWSWIRE
    12 Sep 2022
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.